Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer’s Disease Pathology
- 6 July 2016
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 53 (4) , 1553-1562
Abstract
Elevated blood glucose and the apolipoprotein (APOE) ɛ 4 allele have both been associated with increased dementia risk; however, the neuropathological mechanisms underlying these associations remain unclear. We examined the impact of APOE genotype and midlife blood glucose on post-mortem vascular and Alzheimer’s disease (AD) neuropathology. Ninety-four participants from the Framingham Heart Study without diagnosed diabetes underwent health examination at midlife and brain autopsy at death. Histopathological measures of vascular and AD neuropathology were obtained and analyzed. Results demonstrated that, among APOE ɛ 4 carriers, elevated blood glucose was associated with more severe AD pathology. There was no such relationship with vascular pathology. In a relatively healthy sample with low vascular risk burden, midlife elevated blood glucose was associated with greater AD pathology among APOE ɛ 4 carriers. A better understanding of interactive effects of APOE genotype and vascular risk on neuropathology has implications for identification of individuals at risk for decline and long-term preventive treatment.Keywords
This publication has 43 references indexed in Scilit:
- Diabetes and the brain: issues and unmet needsNeurological Sciences, 2014
- Association of type 2 diabetes with brain atrophy and cognitive impairmentNeurology, 2014
- Higher glucose levels associated with lower memory and reduced hippocampal microstructureNeurology, 2013
- Glucose Levels and Risk of DementiaNew England Journal of Medicine, 2013
- Improved diabetes control in the elderly delays global cognitive declineThe Journal of nutrition, health and aging, 2011
- Improving Metabolic Control Leads to Better Working Memory in Adults With Type 2 DiabetesDiabetes Care, 2006
- The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly PersonsJAMA, 1999
- Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.1997
- Cerebrovascular Disease, the Apolipoprotein e4 Allele, and Cognitive Decline in a Community-Based Study of Elderly MenStroke, 1996
- Probability of stroke: a risk profile from the Framingham Study.Stroke, 1991